Infliximab Reverses Suppression of Cholesterol Efflux Proteins by TNF-α: A Possible Mechanism for Modulation of Atherogenesis

Tumor necrosis factor- (TNF-) α is a proinflammatory proatherogenic cytokine. Infliximab, an anti-TNF-α monoclonal antibody, is effective in treating rheumatoid arthritis. However, its impact on cardiovascular burden and lipid transport is unclear. The present study investigates the effect of TNF-α...

Descripción completa

Detalles Bibliográficos
Autores principales: Voloshyna, Iryna, Seshadri, Sangeetha, Anwar, Kamran, Littlefield, Michael J., Belilos, Elise, Carsons, Steven E., Reiss, Allison B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920897/
https://www.ncbi.nlm.nih.gov/pubmed/24587984
http://dx.doi.org/10.1155/2014/312647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920897/
https://www.ncbi.nlm.nih.gov/pubmed/24587984
http://dx.doi.org/10.1155/2014/312647

Ejemplares similares